Thought Leadership
Insulin Under the BPCIA: Opportunities and Obstacles
April 22, 2020
Ted Mathias and Stacie L. Ropka, PhD
Biosimilar Development

Axinn partners Ted Mathias and Stacie Ropka authored the Biosimilar Development article, "Insulin Under the BPCIA: Opportunities and Obstacles."

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.